Tetract   VACCINE
€ 29.00
Add to Cart
Such combination vaccine is recommended for both the prevention of pertussis, diphtheria and tetanus, and invasive infections caused by Haemophilus Influenzae type b, such as eg meningig, septicemia (blood infection), epiglottitis (acute inflammation of the pharynx and larynx), cellulitis, arthritis .

Tetract - VACCINE

Act-HIV ( powder in a vial )
Drugs :
Polysaccharide of Haemophilus Influenzae type b 10 ?g
conjugated to tetanus protein (24 ?g)
Trometamol 0.6 mg and 42.5 mg sucrose
D.T. COQ / DTP ( suspension in a pre-filled syringe in a dose of 0.5 ml .
Drugs :
Purified diphtheria toxoid - ? 30 IU
Purified tetanus toxoid - ? 60 IU
Bordetella pertussis, inactivated - ? 4 IU
Aluminum hydroxide ( quantity is expressed as aluminum) - 0.65 mg
Thiomersal - ? 0,05 mg
A buffer solution containing sodium chloride , disodium phosphate dihydrate, potassium dihydrogen phosphate, acetic acid and / or sodium hydroxide and water for injection. - Up to 0.5 ml
Powder in a vial and suspension in pre-filled syringe for injection suspension.
 The injectable suspension of TETRAct-HIV was prepared by dissolving the powder of one vial with the Act-HIV suspension of a prefilled syringe DT COQ / DTP ( absorbed vaccine against pertussis , tetanus and diphtheria ) One vial and a prefilled syringe contains one dose of vaccine .
This medicine is a vaccine .
Such combination vaccine is recommended for both the prevention of pertussis, diphtheria and tetanus , and invasive infections caused by Haemophilus Influenzae type b, such as eg meningig , septicemia ( blood infection ) , epiglottitis ( acute inflammation of the pharynx and larynx ) , cellulitis, arthritis , children under the age of 2 months to 5 years of age , non-immunized against any of these diseases.
TETRAct-HIV does not protect against infections caused by other types of Haemophilus influenzae than type b, meningitis or other causes .
This vaccine should not be used in the following cases :
- Progressive encephalopathy with or without seizures ( neurological disease )
- Encephalopathy in the first 7 days after administration of the previous dose of vaccine containing pertussis without any other reason.
- Strong overall reaction occurring within 48 hours after previous administration of a vaccine containing pertussis :
fever above 39,5 ? C ( axillary ) , unless no other reason for this
continuous, inconsolable crying for more than 3 hours
seizures , with or without fever
syndrome of hypertension / hyporesponsive
- Hypersensitivity reactions have been encountered in previous vaccination with this vaccine.
- Known allergy to any component of the vaccine.
 Immunisation is done after examination by a physician .
Vaccination should be postponed in case of fever, acute illness or particularly infectious disease , chronic disease in acute stage .
 - If there is evidence of seizures , without fever , that are not related to previous vaccination, should seek expert advice before deciding to vaccination.
- If the child has had seizures at a high temperature , which are not related to previous vaccination, it is essential to monitor the temperature for 48 hours after vaccination and in those 48 hours , and given regular lowering drugs temperature .
- In children with congenital or acquired immunodeficiency, vaccination can be done having in mind that the condition of the immune system, the immune response may be weaker .
- In case of edema of the lower limbs , occurring after a previous vaccination against Haemophilus influenzae type b, not apply TETRAct-HIV, and vaccine Defter , tetanus, pertussis and separated from it - conjugate vaccine against Haemophilus influenzae type b. In this case, the individual vaccine is given at two different injection sites and on different days .
- If immunosuppressive treatment or immunodeficiency effect of vaccination may be less .
 Inform the doctor if you or your child have any allergies or have ever had an unusual reaction to a previous vaccination.
Interactions :
 There are no contraindications for concomitantly administered vaccine with other routine vaccines matched during use in the immunization calendar , provided that using separate syringes and needles and other injection sites .
Pregnancy and lactation
 Seek advice from your doctor before use. This vaccine is for children.
 Primary vaccination: two months of age are administered in three doses , one dose ( 0.5 mL ) vaccine at intervals of one month between them .
Booster : one dose one year after the third injection of the primary vaccination.
The vaccine is administered after reconstitution of the lyophilized powder Act-HIV in the vial with the suspension of a pre-filled syringe (DT COQ / DTP)
Before injection into the vial , syringe DT COQ / DTP must be shaken until complete dissolution of the powder, without the development of foam .
After reconstitution, the suspension is normal to be cloudy whitish.
It is recommended that the vaccine be administered in the anterolateral aspect of the thigh ( middle third ) . Injected immediately after reconstitution.
Do not inject intravascularly.
 The injection site can be observed pain, redness , induration and edema, occurring within 48 hours after vaccination and lasting up to several days. Formation of subcutaneous node that disappears within a few weeks , you may accompany these reactions. Rare cases of aseptic abscesses .
Fever over 38 ? C, unusual crying during the first 24 to 48 hours after vaccination.
Allergic reactions: skin rash , urticaria and anaphylactic shock exception ( allergic shock) or Quincke's edema ( a form of urticaria with sudden swelling of the face and neck )
Very rarely, collapse or shock ( low blood pressure or hyporesponsive ) , constant crying , convulsions with or without fever .
Edema of the lower extremities with bruising or redness spotted passing , sometimes accompanied by fever, pain and tears.
The shelf life is 3 years
Vaccine after reconstitution , be used immediately
€ 29.00
Add to Cart